Full Indication
Opdualag® (nivolumab and relatlimab-rmbw) is a prescription medicine used to treat adults and children 12 years of age or older with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma). It is not known if Opdualag is safe and effective when used in children 12 years of age or older who weigh less than 88 pounds (40 kg), or in children younger than 12 years of age.
Prescribing Information
Medication Guide
For Healthcare Professionals
Sign up for Support
All images are actor portrayals.
HOME
ABOUT MELANOMA
ABOUT OPDUALAG
Efficacy
Side Effects
STARTING OPDUALAG
Working With Your Doctor
COST & FINANCIAL INFO
EDUCATION & SUPPORT
Patient & Caregiver Videos